{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:03:11Z","timestamp":1788397391456,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.transproceed.2020.01.159","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T07:34:28Z","timestamp":1592638468000},"page":"1829-1832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Safety and Efficacy of Everolimus Rescue Treatment After Pediatric Living Donor Liver Transplantation"],"prefix":"10.1016","volume":"52","author":[{"given":"Takehisa","family":"Ueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonari","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Tazuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Bessho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.01.159_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/MOT.0b013e32833da439","article-title":"Renal function in the long term after pediatric liver transplantation: is there a need for protocol kidney biopsies?","volume":"15","author":"Campbell","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2020.01.159_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/TP.0b013e3181d2fec1","article-title":"Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network\/United Network for Organ Sharing database","volume":"89","author":"Kuo","year":"2010","journal-title":"Transplantation"},{"issue":"Suppl. 3","key":"10.1016\/j.transproceed.2020.01.159_bib3","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/lt.22386","article-title":"Metabolic syndrome: is immunosuppression to blame?","volume":"17","author":"Watt","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.01.159_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5223\/pghn.2013.16.4.207","article-title":"Long term outcomes after pediatric liver transplantation","volume":"16","author":"Yazigi","year":"2013","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"10.1016\/j.transproceed.2020.01.159_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-3046.2011.01515.x","article-title":"The use of everolimus in pediatric liver transplant recipients: first experience in a single center","volume":"15","author":"Nielsen","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2020.01.159_bib6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4254\/wjh.v9.i23.990","article-title":"Use of everolimus in liver transplantation","volume":"9","author":"Yee","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.transproceed.2020.01.159_bib7","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.01.159_bib8","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/lt.20707","article-title":"Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results","volume":"12","author":"Levy","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.01.159_bib9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/lt.21827","article-title":"Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial","volume":"15","author":"De Simone","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.01.159_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.159_bib11","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.159_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1432-2277.2008.00768.x","article-title":"Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function","volume":"22","author":"De Simone","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2020.01.159_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00007890-200002270-00006","article-title":"SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts","volume":"69","author":"Viklicky","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.01.159_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13024","article-title":"Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: results from a multicenter, prospective study","volume":"21","author":"Ganschow","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2020.01.159_bib15","unstructured":"Novartis, afinitor (everolimus) prescribing information. 2020. https:\/\/www.novartis.us\/sites\/www.novartis.us\/files\/afinitor.pdf. [accessed 27.04.20]."},{"key":"10.1016\/j.transproceed.2020.01.159_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/tri.12372","article-title":"Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review","volume":"27","author":"Cholongitas","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2020.01.159_bib17","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.ejca.2011.12.032","article-title":"Rapamycin blocks hepatoblastoma growth in\u00a0vitro and in\u00a0vivo implicating new treatment\u00a0options in high-risk patients","volume":"48","author":"Wagner","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.transproceed.2020.01.159_bib18","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.transproceed.2018.03.079","article-title":"Everolimus rescue treatment for chronic rejection after pediatric living donor liver transplantation: 2 case reports","volume":"50","author":"Ueno","year":"2018","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519318263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519318263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:35:28Z","timestamp":1758576928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519318263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0041134519318263"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.159","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Everolimus Rescue Treatment After Pediatric Living Donor Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}